TOMSK, RUSSIA / RankWire.AI / – Russian scientists have developed and tested a bioactive surface layer aimed at enhancing the integration of titanium orthopaedic implants with bone tissue. This coating incorporates calcium phosphate obtained from hydroxyapatite and includes nitrogen compounds linked to nitric oxide production. Laboratory experiments demonstrated a significantly increased survival rate of human mesenchymal stem cells on coated surfaces compared to uncoated titanium. The team analyzed the coating’s structural, chemical, mechanical, and biological properties. Their peer-reviewed results were published in Applied Surface Science in 2026.
At Tomsk Polytechnic University, researchers produced the experimental coatings through reactive magnetron sputtering of a hydroxyapatite target within a vacuum chamber. They adjusted the nitrogen-to-argon ratio during the process to observe how each mixture influenced the resulting surface. The study tested five different conditions, from pure nitrogen to pure argon. They then measured parameters such as coating thickness, surface morphology, hardness, wettability, and chemical composition. Additionally, laboratory tests assessed how living human cells responded to the modified titanium surfaces.
The results indicated that the argon content influenced several physical characteristics of the coatings. Surfaces created with pure argon were denser and harder than those formed in pure nitrogen. As the proportion of argon increased, coating thickness also grew. Chemical analysis detected nitrogen-carbon and nitrogen-oxygen bonds on the modified surfaces. The team then compared the behavior of human mesenchymal stem cells cultivated on coated titanium with cells on uncoated titanium. The biological evaluations focused on cell viability and markers associated with osteogenic differentiation.
Enhanced Cell Viability Seen in Coating Tests
The cell experiments indicated a marked improvement in survival rates on coated titanium surfaces compared to uncoated samples, according to the published findings. After a seven-day period, coatings with higher nitrogen levels also appeared to suppress activity in certain genes linked to early bone cell differentiation. Despite this, the cells maintained their ability to form bone tissue. The researchers conducted these tests under controlled laboratory conditions using human mesenchymal stem cells. It is important to note that the study did not involve testing in patients or evaluating the clinical performance of actual medical implants.
The biomedical evaluation was carried out by specialists from Immanuel Kant Baltic Federal University and Siberian State Medical University, with additional contributions from Saint Petersburg State University. The project was supported by Russia’s state science program. The research aimed to identify gas mixtures capable of producing coatings with optimal physical, chemical, and biological properties. Hydroxyapatite is already used in implant coatings due to its calcium phosphate composition, which closely resembles the mineral component of human bone.
Current Findings Are Limited to Laboratory Investigations
The researchers plan to extend their testing beyond the initial seven-day cell study. They intend to examine stem cell behavior over periods of 10 to 28 days and evaluate the rate of coating dissolution as well as nitric oxide release into tissue in living organisms. These future investigations were not part of the current published results. Presently, the focus remains on coated titanium substrates, their physical and chemical characteristics, and in vitro cellular responses, rather than clinical outcomes in orthopaedic patients.
The study offers comprehensive laboratory data on how different ratios of nitrogen and argon influence calcium phosphate coatings on titanium surfaces. The researchers documented variations in thickness, density, hardness, chemical bonds, and cellular response across the tested gas mixtures. Their work confirmed that coated samples supported higher stem-cell survival than bare titanium under laboratory conditions. However, the research remains in the preclinical phase, and the results do not establish safety or efficacy for human use. Additional biological tests will be necessary to evaluate properties not addressed in this study.